Posted by SLS on April 22, 2016, at 5:08:13
In reply to Valdoxan didn't fair too well in studies » JohnWatford, posted by TriedEveryMedication on April 22, 2016, at 1:59:40
> a meta-analysis of valdoxan suggests it is a pretty poor AD.
>
> a 0.24 effect size can be conceptualized like this: If you were shown a the test results of someone in the study, you'd only have a 55% chance of guessing that person was taking the valdoxan and not the placebo.
>
> http://www.jwatch.org/na34076/2014/03/31/agomelatine-effective-antidepressantInterestingly, I know someone whose rapid-cycling bipolar disorder was stabilized on valdoxan. After it was added to his other medication, it prevented him from cycling and left him feeling normal. This is just one person, though.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1088305
URL: http://www.dr-bob.org/babble/20160331/msgs/1088376.html